Summary of Key Points Core Viewpoint - The company Kintor Pharmaceutical Co., Ltd. has been actively repurchasing its shares, indicating a strategy to support its stock price amid recent declines [2][3]. Group 1: Share Buyback Activity - On November 24, Kintor repurchased 360,000 shares at a price range of HKD 15.880 to HKD 16.750, totaling HKD 5.9567 million [2]. - The stock closed at HKD 15.880 on the same day, reflecting a decline of 6.15%, with a total trading volume of HKD 103 million [2]. - Since November 20, the company has conducted share buybacks for three consecutive days, accumulating a total of 763,000 shares repurchased and a total expenditure of HKD 12.914 million, during which the stock price fell by 8.26% [2]. Group 2: Year-to-Date Buyback Summary - Year-to-date, Kintor has executed nine buyback transactions, repurchasing a total of 4.1855 million shares for a cumulative amount of HKD 66.6845 million [3]. - The detailed buyback transactions include various dates, share quantities, and price ranges, showcasing a consistent effort to stabilize the stock price [3].
科济药业-B(02171.HK)11月24日回购36.00万股，耗资595.67万港元